Maintained response to treatment with anti-CD20 antibodies (Rituximab) in a case autoimmune haemolytic anaemia associated with rheumatoid arthritis.

被引：3
|
作者：
Barquero-Romero, J [1 ]
Domínguez, MG
Miranda, MP
机构：
[1] Univ Badajoz, Med Interna Serv, Hosp Perpetuo Socorro, Complejo Hosp, Badajoz, Spain
[2] Univ Badajoz, Serv Hematol, Hosp Perpetuo Socorro, Complejo Hosp, Badajoz, Spain
来源：
MEDICINA CLINICA | 2005年 / 124卷 / 13期
关键词：
D O I：
10.1157/13073571
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：517 / 518
页数：2
相关论文
共 50 条
  • [1] Treatment of refractory autoimmune haemolytic anaemia with anti-CD20 (rituximab)
    Ahrens, N
    Kingreen, D
    Seltsam, A
    Salama, A
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 114 (01) : 244 - 245
  • [2] Childhood refractory autoimmune haemolytic anaemia: Is there a role for anti-CD20 therapy (rituximab)?
    Mc Mahon, C
    Babu, L
    Hodgson, A
    Hayat, A
    Connell, NO
    Smith, OP
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 117 (02) : 480 - 482
  • [3] Anti-CD20 Antibody Rituximab in the Treatment of Rheumatoid Arthritis
    Korhonen, Riku
    Moilanen, Eeva
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2010, 106 (01) : 13 - 21
  • [4] Anti-CD20 monoclonal antibody (rituximab) to treat autoimmune haemolytic anaemia: Report of six cases
    Jackson, N
    Macwhannell, A
    Slocombe, G
    Stockley, R
    Chapman, O
    Basu, S
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 : 72 - 72
  • [5] Anti-CD20 monoclonal antibody (rituximab) therapy in a child with refractory chronic autoimmune haemolytic anaemia
    Kerridge, I
    Hann, I
    Ethel, M
    Potter, M
    Prentice, HG
    INTERNAL MEDICINE JOURNAL, 2003, 33 (11) : 544 - U3
  • [6] Anti-CD20 monoclonal antibody for the treatment of refractory autoimmune haemolytic anaemia associated with idiopathic membranous nephropathy
    Rossi, P
    Demoux, AL
    Granel, B
    Bagnères, D
    Bonin-Guillaume, S
    Frances, Y
    RHEUMATOLOGY, 2005, 44 (03) : 403 - 405
  • [7] Treatment of refractory fludarabine induced autoimmune haemolytic with the anti-cd20 monoclonal antibody rituximab
    Swords, R
    Nolan, A
    Fay, M
    Quinn, J
    O'Donnell, R
    Murphy, PT
    CLINICAL AND LABORATORY HAEMATOLOGY, 2006, 28 (01): : 57 - 59
  • [8] THE INVESTIGATION OF INFLUENCE OF THE TREATMENT WITH ANTI-CD20 ANTIBODIES (RITUXIMAB) ON BONE MINERAL DENSITY IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Dydykina, P.
    Dydykina, I.
    Devyataikina, A.
    Lukina, G.
    Smimov, A.
    Nasonov, E.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 : S262 - S262
  • [9] Rituximab (anti-CD20) for the treatment of autoimmune bullous diseases
    Kasperkiewicz, M.
    Zillikens, D.
    HAUTARZT, 2007, 58 (02): : 115 - +
  • [10] Anti-CD20 for rheumatoid arthritis
    Edwards, JC
    Leandro, MJ
    Cambridge, G
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 25 - 25
12345